Author
Listed:
- Ming-Dow Tsay
(Institute of Medicine, Chung Shan Medical University, Taichung 402, Taiwan
Department of Family medicine, Tungs’ Taichung MetroHarbor Hospital, Taichung 433, Taiwan
These authors contributed equally to the work.)
- Ming-Ju Hsieh
(Institute of Medicine, Chung Shan Medical University, Taichung 402, Taiwan
Cancer Research Center, Changhua Christian Hospital, Changhua 500, Taiwan
Graduate Institute of Biomedical Sciences, China Medical University, Taichung 404, Taiwan
These authors contributed equally to the work.)
- Chia-Yi Lee
(Department of Ophthalmology, Show Chwan Memorial Hospital, Changhua 500, Taiwan
Department of Optometry, College of Medicine and Life Science, Chung Hwa University of Medical Technology, Tainan 717, Taiwan)
- Shian-Shiang Wang
(Institute of Medicine, Chung Shan Medical University, Taichung 402, Taiwan
School of Medicine, Chung Shan Medical University, Taichung 402, Taiwan
Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung 407, Taiwan
Department of Applied Chemistry, National Chi Nan University, Nantou 545, Taiwan)
- Chuan-Shu Chen
(Institute of Medicine, Chung Shan Medical University, Taichung 402, Taiwan
Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung 407, Taiwan)
- Sheng-Chun Hung
(Institute of Medicine, Chung Shan Medical University, Taichung 402, Taiwan
School of Medicine, Chung Shan Medical University, Taichung 402, Taiwan
Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung 407, Taiwan)
- Chia-Yen Lin
(Institute of Medicine, Chung Shan Medical University, Taichung 402, Taiwan
Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung 407, Taiwan)
- Shun-Fa Yang
(Institute of Medicine, Chung Shan Medical University, Taichung 402, Taiwan
Department of Medical Research, Chung Shan Medical University Hospital, Taichung 402, Taiwan)
Abstract
Fibroblast growth factor receptor 4 (FGFR4) plays a prominent role in cell proliferation and cancer progression. This study explored the effect of FGFR4 single-nucleotide polymorphisms (SNPs) on the clinicopathological characteristics of urothelial cell carcinoma (UCC). This study was conducted to survey the possible correlation of the polymorphism of FGFR4 to the risk and clinicopathologic characteristics of UCC. Four loci of FGFR4 (rs2011077 T > C, rs351855 G > A, rs7708357 G>A, and rs1966265 A > G) were genotyped via the TaqMan allelic discrimination approach in 428 UCC cases and 856 controls. The results indicated that UCC subjects who carried the SNP rs2011077 TC+CC genotypes were significantly related to a higher tumor stage (odds ratio (OR): 1.751, 95% confidence interval (CI): 1.078–2.846), primary tumor size (OR: 1.637, 95% CI: 1.006–2.662), and histopathologic grading (OR: 1.919, 95% CI: 1.049–3.511). Moreover, the SNP rs1966265 AG+GG genotypes were prominently related to a higher tumor stage (OR: 1.769, 95% CI: 1.082–2.891), primary tumor size (OR: 1.654, 95% CI: 1.011–2.706), and histopathologic grading (OR: 2.006, 95% CI: 1.096–3.674) compared to individuals with AA homozygotes. In conclusion, our data reveal association of FGFR4 polymorphisms with UCC clinicopathologic characteristics. FGFR4 polymorphisms may serve as a marker or therapeutic target in UCC development.
Suggested Citation
Ming-Dow Tsay & Ming-Ju Hsieh & Chia-Yi Lee & Shian-Shiang Wang & Chuan-Shu Chen & Sheng-Chun Hung & Chia-Yen Lin & Shun-Fa Yang, 2019.
"Involvement of FGFR4 Gene Variants on the Clinicopathological Severity in Urothelial Cell Carcinoma,"
IJERPH, MDPI, vol. 17(1), pages 1-9, December.
Handle:
RePEc:gam:jijerp:v:17:y:2019:i:1:p:129-:d:301305
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:17:y:2019:i:1:p:129-:d:301305. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.